Related Articles

Clinical Trial Experiences of Patients

Amicus Therapeutics Announces First Patient in Phase 2 Study for Pompe Disease





SARI
BartJan

Related Articles

ADVANCE Study Fact Sheet
ADVANCE Study Fact Sheet
Community Update for Pompe Families in the United States who Utilize Myozyme®
AMICUS POMPE COMMUNITY UPDATE
Amicus Therapeutics Announces FDA Agreement to Commence Phase 2 Study of AT2220 Co-administered with Enzyme Replacement Therapy for Pompe Disease
Amicus Therapeutics Announces FDA Agreement to Commence Phase 2 Study of AT2220 Co-administered with Enzyme Replacement Therapy for Pompe Disease
Sanofi-aventis to Acquire Genzyme
Sanofi-aventis to Acquire Genzyme
POMPE in COMMON
United States Pompe Program Update, August 9, 2010
United States Pompe Program Update, May 25, 2010
LUMIZYME APPROVAL
US Pompe Program Update – December 3, 2009
US Pompe Program Update – December 3, 2009
US Pompe Program Update - November 16, 2009
Pompe Program Update ? May 22, 2009
HOME ADAPTIONS FOR SAFETY AND ACCESSIBILITY
Pompe Program Update March 2, 2009
Genzyme Receives Complete Response Letter from FDA
MYOZYME® (2000 L) SUPPLY UPDATE_US VERSION_JANUARY 2009
Guidance to the Pompe Community on the
Genzyme Pompe Program Update- November 17, 2008
Myozyme Produced at the 2000 L Bioreactor Scale to Receive Accelerated Approval
Genzyme Program Update November 10th, 2008
Amicus Therapeutics Begins Phase 2 Clinical Trial of AT2220 in Pompe Disease
US Myozyme Manufacturing Update - April 2008
Genzyme Provides Update on Myozyme® Manufacturing
Amicus Therapeutics Presents Data from Clinical Ex Vivo Response Study
January 2008 US Myozyme Supply Update*
Genzyme Study of Myozyme® for Late-Onset Pompe Patients Meets Co-Primary Efficacy Endpoints
Amicus Therapeutics and Shire plc Enter Into $440 Million ex-US Licensing Agreement
Amicus Therapeutics Announces Positive Results From Two Phase 1 Clinical Studies of
October Update on the US Myozyme® Supply
Rehabilitation Management of Pompe Disease
JOINT LETTER FROM THE AMDA AND UPF
Therapy -- It's Here, and Free
US Myozyme® Supply Update July 25, 2007
MTAP Fact Sheet July 2007
GENZYME POMPE PROGRAM UPDATE JUNE 2007
MTAP FACT SHEET JUNE 2007
Pompe Program Update May 2007
Myozyme® Temporary Access Program
Flying with a ventilator in the USA
GENZYME POMPE PROGRAM APRIL 2007
Genzyme Update on the LOTS Trial- January 2007
AMICUS THERAPEUTICS COMMENCES PHASE 1 CLINICAL TRIALS FOR AT2220 FOR POMPE DISEASE
The Myozyme Miracle
FDA Approves Genzyme's Myozyme® for All Patients with Pompe Disease
European Commission Approves Genzyme's Myozyme®
Expensive drug gives hope to rare disease sufferer
Genzyme Provides Update on U.S. Marketing Application for Myozyme®
Myozyme® Receives Positive Opinion from European Regulatory Committee
October 2005 Pompe Program Update
Genzyme Begins Trial of Myozyme® for Patients with Late-Onset Pompe Disease
Genzyme Submits BLA for Myozyme® for Treatment of Pompe Disease
Pompe Program Update July 2005
Pompe Program Update March 2005
Pompe Program Update December 2004
Genzyme Files for European Approval of Myozyme For Treatment of Pompe Disease
IPA /Genzyme Joint Pompe Program Update, August 2004
Genzyme Pompe Program Update May 2004
IPA Summary of Genzyme Press Release
Q AND A SESSION GENZYME IPA CONFERENCE NOVEMBER 2003
Genzyme Expands MyozymeTM
IPA/GENZYME JOINT PROGRAM UPDATE
Genzyme Pompe Program Update February 18, 2003
Genzyme Pompe Program Update December 2002
IPA/Genzyme Meeting
Letter From Jan van Heek
Rescue of enzyme deficiency in embryonic diaphragm in a mouse
Long-Term Intravenous Treatment of Pompe Disease With Recombinant Human a-Glucosidase From Milk
Upcoming Events/New Items Links

DUKE UNIVERSITY-UNITED POMPE FOUNDATION POMPE PATIENT MEETING

Pompe Family Meeting

Community Update for Pompe Families in the United States who Utilize Myozyme®

ADVANCE Study Fact Sheet

Amicus Therapeutics Announces First Patient in Phase 2 Study for Pompe Disease

AMICUS POMPE COMMUNITY UPDATE NEWSLETTER

Amicus Therapeutics Announces FDA Agreement to Commence Phase 2 Study of AT2220 Co-administered with Enzyme Replacement Therapy for Pompe Disease

Sanofi-aventis to Acquire Genzyme

BioMarin Initiates Phase 1/2 Trial for BMN 701 for the Treatment of Pompe Disease

POMPE IN COMMON WINTER 2010 EDITION

GENZYME: THE MAKING OF PROTEIN THERAPIES VIDEO

United States Pompe Program Update, August 9, 2010

UNITED STATES POMPE PROGRAM UPDATE, MAY 25, 2010

GENZYME RECEIVES FDA APPROVAL FOR LUMIZYME FOR POMPE DISEASE

US Pompe Program Update – December 3, 2009

POMPE PROGRAM UPDATE MAY 22, 2009

Pompe Program Update March 2, 2009

Genzyme Receives Complete Response Letter from FDA on Lumizyme Application

MYOZYME® (2000 L) SUPPLY UPDATE _US VERSION_JANUARY 2009

GUIDANCE TO THE POMPE COMMUNITY ON THE MANAGEMENT OF MYOZYME SUPPLY

GENZYME POMPE PROGRAM UPDATE NOVEMBER 17, 2008

MYOZYME PRODUCED AT THE 2000L BIOREACTOR SCALE TO RECEIVE ACCELERATED APPROVAL

Amicus Therapeutics Begins Phase 2 Clinical Trial of AT2220 in Pompe Disease

Genzyme Provides Update on Myozyme® Manufacturing

Genzyme Study of Myozyme® for Late-Onset Pompe Patients Meets Co-Primary Efficacy Endpoints

Amicus Therapeutics Announces Positive Results From Two Phase 1 Clinical Studies of AT2220 for Pompe Disease

REHABILITATION MANAGEMENT OF POMPE DISEASE: GREGORY T. CARTER, MD, MS

THE MYOZYME MIRACLE

FDA APPROVES GENZYMES MYOZYME® FOR ALL PATIENTS WITH POMPE DISEASE

Expensive drug gives hope to rare disease sufferer

POMPE INCOMMON

New Zealand Pompe Network website

LUMIZYME HOME PAGE

HOME ADAPTIONS: SHARON KRUEGER

Canadian Association of Pompe

"WEAKLING WILLIE" BOOK

FLYING WITH A VENTILATOR IN THE USA

Association for Glycogen Storage Disease

JUAN MAGDARAOG BLOG

Myozyme Home Page

EXPRESSION OF HOPE

Amicus Therapeutics

UK Pompe Group

Helping Hands Loving Hearts

International Pompe Association IPA

Clinical Trial Information

Genzyme's Pompe Website

Pompe Disease | Clinical Trial Process | Donations | EP Magazine Article "Living With Pompe Disease"
Events | Guest Book | Patient Registry | Videos | Related Articles | Contact Us | Home
United Pompe 2012 All Rights Reserved.